Search Results

There are 7722 results for: content related to: Remobilization of hematopoietic stem cells with high-dose methotrexate and cytarabine in patients with non- H odgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines

  1. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1243–1250, Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen and Esa Jantunen

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12434

  2. UK consensus statement on the use of plerixafor to facilitate autologous Peripheral Blood Stem Cell collection to support high-dose chemoradiotherapy for patients with malignancy

    Journal of Clinical Apheresis

    Kenneth W. Douglas, Maria Gilleece, Patrick Hayden, Hannah Hunter, Peter R. E. Johnson, Charlotte Kallmeyer, Ram K. Malladi, Shankara Paneesha, Rachel Pawson, Michael Quinn, Kavita Raj, Deborah Richardson, Stephen Robinson, Nigel Russell, John Snowden, Anna Sureda, Eleni Tholouli, Kirsty Thomson, Mike Watts and Keith M. Wilson

    Version of Record online : 20 JUN 2017, DOI: 10.1002/jca.21563

  3. Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization

    Transfusion

    Volume 54, Issue 8, August 2014, Pages: 2015–2021, Shan Yuan, Auayporn Nademanee, Mark Kaniewski, Joycelynne Palmer, Sepideh Shayani and Shirong Wang

    Version of Record online : 24 MAR 2014, DOI: 10.1111/trf.12594

  4. Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent

    Transfusion

    Volume 53, Issue 12, December 2013, Pages: 3244–3250, Shan Yuan, Auayporn Nademanee, Amrita Krishnan, Neil Kogut, Sepideh Shayani and Shirong Wang

    Version of Record online : 22 APR 2013, DOI: 10.1111/trf.12198

  5. Plerixafor in combination with granulocyte–colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2351–2357, Neera Jagirdar, R. Donald Harvey, Ajay Nooka, Christopher Flowers, Jonathan Kaufman, Sagar Lonial, Mary Jo Lechowicz, Amelia Langston, Carol Lipscomb, Cynthia Gaylor and Edmund K. Waller

    Version of Record online : 2 SEP 2015, DOI: 10.1111/trf.13186

  6. Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony-stimulating factor

    Transfusion

    Volume 55, Issue 5, May 2015, Pages: 1021–1027, Yavuz M. Bilgin, Otto Visser, Erik A.M. Beckers, Liane CJ te Boome, Cynthia Huisman, Paula F. Ypma, Alexandra J. Croockewit, Tanja Netelenbos, Ellen PA Kramer and Georgine E. de Greef

    Version of Record online : 30 DEC 2014, DOI: 10.1111/trf.12979

  7. You have free access to this content
    How do we mobilize and collect autologous peripheral blood stem cells?

    Transfusion

    Volume 57, Issue 1, January 2017, Pages: 13–23, Shan Yuan and Shirong Wang

    Version of Record online : 12 OCT 2016, DOI: 10.1111/trf.13868

  8. The evolving role of plerixafor in hematopoietic progenitor cell mobilization

    Transfusion

    Volume 53, Issue 10, October 2013, Pages: 2314–2326, Yvette C. Tanhehco, Dan T. Vogl, Edward A. Stadtmauer and Una O'Doherty

    Version of Record online : 30 JAN 2013, DOI: 10.1111/trf.12102

  9. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2358–2368, Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Anne Nihtinen, Anu Partanen, Kaija Vasala, Päivi Lehtonen, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Tapio Nousiainen, Jukka Pelkonen, Pentti Mäntymaa and Esa Jantunen

    Version of Record online : 28 MAY 2015, DOI: 10.1111/trf.13170

  10. A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the “on-demand” scheme of administration at French autologous hematopoietic stem cell transplant programs

    Transfusion

    Volume 55, Issue 9, September 2015, Pages: 2149–2157, Christian Chabannon, Fontanet Bijou, Jean-Michel Miclea, Noel Milpied, Jean-Marie Grouin and Mohamad Mohty

    Version of Record online : 13 MAY 2015, DOI: 10.1111/trf.13141

  11. You have full text access to this OnlineOpen article
    Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

    Transfusion

    Volume 55, Issue 2, February 2015, Pages: 275–283, Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens-Harig, Kai Neben, Michael Hundemer, Jens Hillengass, Renate Alexi, Hartmut Goldschmidt, Bao-an Chen, Anthony D. Ho and Anita Schmitt

    Version of Record online : 13 AUG 2014, DOI: 10.1111/trf.12813

  12. The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34+ cells

    Journal of Clinical Apheresis

    Volume 27, Issue 2, 2012, Pages: 81–87, Ajay K. Gopal, Mehdi Karami, JoAl Mayor, Mylene Macebeo, Michael Linenberger, William I. Bensinger and Leona Holmberg

    Version of Record online : 2 FEB 2012, DOI: 10.1002/jca.21206

  13. Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept

    Transfusion

    Volume 52, Issue 4, April 2012, Pages: 906–914, Esa Jantunen and Roberto M. Lemoli

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1537-2995.2011.03349.x

  14. You have full text access to this OnlineOpen article
    The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor

    Transfusion

    Volume 54, Issue 9, September 2014, Pages: 2325–2335, Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger and Tanja Nicole Hartmann

    Version of Record online : 28 MAR 2014, DOI: 10.1111/trf.12632

  15. Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings

    Transfusion

    Gabriel Park, Sepideh Shayani, Tracey Stiller, Shirong Wang and Shan Yuan

    Version of Record online : 13 NOV 2017, DOI: 10.1111/trf.14395

  16. You have free access to this content
    Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis

    Transfusion

    Volume 57, Issue 1, January 2017, Pages: 115–121, Silvia Spoerl, Robert Peter, Dagmar Wäscher, Katharina Götze, Mareike Verbeek, Christian Peschel and Angela M. Krackhardt

    Version of Record online : 18 NOV 2016, DOI: 10.1111/trf.13883

  17. Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1263–1268, Patricia A. Shi, Lorraine K. Miller and Luis M. Isola

    Version of Record online : 16 OCT 2013, DOI: 10.1111/trf.12459

  18. Intermediate doses of cytarabine plus granulocyte–colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure

    Transfusion

    Volume 55, Issue 4, April 2015, Pages: 875–879, Cristina Calderón-Cabrera, Magdalena Carmona González, Jesús Martín, Eduardo Ríos Herranz, Pilar Noguerol, Fátima De la Cruz, Estrella Carrillo, Jose F. Falantes, Rocío Parody, Ildefonso Espigado and Jose A. Pérez-Simón

    Version of Record online : 29 OCT 2014, DOI: 10.1111/trf.12906

  19. A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration

    Transfusion

    Volume 55, Issue 8, August 2015, Pages: 2010–2016, Emily Storch, Tomer Mark, Scott Avecilla, Carlos Pagan, Joanna Rhodes, Tsiporah Shore, Koen van Besien and Melissa Cushing

    Version of Record online : 21 MAR 2015, DOI: 10.1111/trf.13076

  20. A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure

    Transfusion

    Volume 53, Issue 3, March 2013, Pages: 564–569, François Lefrère, Laeticia Mauge, Delphine Réa, Jean-Antoine Ribeil, Liliane Dal Cortivo, Anne C. Brignier, Charbel Aoun, Jérôme Larghéro, Marina Cavazzana-Calvo and Jean-Michel Micléa

    Version of Record online : 21 JUN 2012, DOI: 10.1111/j.1537-2995.2012.03744.x